AAAAAA
Results: 76-100/1150
Authors:
de Souza, MHO
Fernandez, TD
Diamond, HR
Maioli, MC
Bacha, PCP
de Lucena, SB
Citation: Mho. De Souza et al., Cytogenetic and immunophenotypic evidence of independent clonal origins ofconcomitant chronic lymphocytic leukaemia and acute myeloid leukaemia, EUR J HAEMA, 66(4), 2001, pp. 281-283
Authors:
Jensen, MK
Brown, PD
Lund, BV
Nielsen, OJ
Hasselbalch, HC
Citation: Mk. Jensen et al., Increased circulating platelet-leukocyte aggregates in myeloproliferative disorders is correlated to previous thrombosis, platelet activation and platelet count, EUR J HAEMA, 66(3), 2001, pp. 143-151
Authors:
Wright, CA
Tefferi, A
Citation: Ca. Wright et A. Tefferi, A single institutional experience with 43 pregnancies in essential thrombocythemia, EUR J HAEMA, 66(3), 2001, pp. 152-159
Authors:
Norgaard, JM
Langkjer, ST
Palshof, T
Pedersen, B
Hokland, P
Citation: Jm. Norgaard et al., Pretreatment leukaemia cell drug resistance is correlated to clinical outcome in acute myeloid leukaemia, EUR J HAEMA, 66(3), 2001, pp. 160-167
Authors:
Dybkaer, K
Olesen, G
Pedersen, FS
Kristensen, JS
Citation: K. Dybkaer et al., Stromal-mediated down-regulation of CD13 in bone marrow cells originating from acute myeloid leukemia patients, EUR J HAEMA, 66(3), 2001, pp. 168-177
Authors:
De Waele, M
Renmans, W
Vander Gucht, K
Jochmans, K
Schots, R
Otten, J
Trullemans, F
Lacor, P
Van Riet, I
Citation: M. De Waele et al., Growth factor receptor profile of CD34(+) cells in AML and B-lineage ALL and in their normal bone marrow counterparts, EUR J HAEMA, 66(3), 2001, pp. 178-187
Authors:
Robak, T
Gora-Tybor, J
Lech-Maranda, E
Blonski, JZ
Robak, T
Citation: T. Robak et al., Cladribine in combination with mitoxantrone and cyclophosphamide (CMC) in the treatment of heavily pre-treated patients with advanced indolent lymphoid malignancies, EUR J HAEMA, 66(3), 2001, pp. 188-194
Authors:
Weimann, G
Lubenow, N
Selleng, K
Eichler, P
Albrecht, D
Greinacher, A
Citation: G. Weimann et al., Glucosamine sulfate does not crossreact with the antibodies of patients with heparin-induced thrombocytopenia, EUR J HAEMA, 66(3), 2001, pp. 195-199
Authors:
Wang, H
Chuhjo, T
Yamazaki, H
Shiobara, S
Teramura, M
Mizoguchi, H
Nakao, S
Citation: H. Wang et al., Relative increase of granulocytes with a paroxysmal nocturnal haemoglobinuria phenotype in aplastic anaemia patients: the high prevalence at diagnosis, EUR J HAEMA, 66(3), 2001, pp. 200-205
Authors:
Hall, RL
Leahy, MF
Citation: Rl. Hall et Mf. Leahy, Acquired Factor VIII autoantibody: four cases demonstrating the heterogenous nature of this condition and problems involved in diagnosis and treatment, EUR J HAEMA, 66(3), 2001, pp. 206-209
Authors:
Abe, Y
Ohshima, K
Shiratsuchi, M
Honda, K
Nishimura, J
Nawata, H
Muta, K
Citation: Y. Abe et al., Cytotoxic T-cell lymphoma presenting as secondary myelofibrosis with high levels of PDGF and TGF-beta, EUR J HAEMA, 66(3), 2001, pp. 210-212
Authors:
Vindelov, L
Citation: L. Vindelov, Allogeneic bone marrow transplantation with reduced conditioning (RC-BMT), EUR J HAEMA, 66(2), 2001, pp. 73-82
Authors:
Sezer, O
Jakob, C
Eucker, J
Niemoller, K
Gatz, F
Wernecke, KD
Possinger, K
Citation: O. Sezer et al., Serum levels of the angiogenic cytokines basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in multiple myeloma, EUR J HAEMA, 66(2), 2001, pp. 83-88
Authors:
Laroche, M
Brousset, P
Ludot, I
Mazieres, B
Thiechart, M
Attal, M
Citation: M. Laroche et al., Increased vascularization in myeloma, EUR J HAEMA, 66(2), 2001, pp. 89-93
Authors:
Aviles, A
Cleto, S
Huerta-Guzman, J
Neri, R
Citation: A. Aviles et al., Interferon alfa 2b as maintenance therapy in poor risk diffuse large B-cell lymphoma in complete remission after intensive CHOP-BLEO regimens, EUR J HAEMA, 66(2), 2001, pp. 94-99
Authors:
Bellido, M
Rubiol, E
Ubeda, J
Lopez, O
Estivill, C
Carnicer, MJ
Munoz, I
Bordes, R
Sierra, J
Nomdedeu, J
Citation: M. Bellido et al., Flow cytometry using the monoclonal antibody CD10-Pe/Cy5 is a useful tool to identify follicular lymphoma cells, EUR J HAEMA, 66(2), 2001, pp. 100-106
Authors:
Varis, I
Deneys, V
Mazzon, AM
De Bruyere, M
Cornu, G
Brichard, B
Citation: I. Varis et al., Expression of HLA-DR, CAM and co-stimulatory molecules on cord blood monocytes, EUR J HAEMA, 66(2), 2001, pp. 107-114
Authors:
Milman, N
Byg, KE
Mulvad, G
Pedersen, HS
Bjerregaard, P
Citation: N. Milman et al., Iron status markers in 224 indigenous Greenlanders: influence of age, residence and traditional foods, EUR J HAEMA, 66(2), 2001, pp. 115-125
Authors:
Laosombat, V
Wongchanchailert, M
Sattayasevana, B
Wiriyasateinkul, A
Fucharoen, S
Citation: V. Laosombat et al., Clinical and hematological features of codon 17, A-T mutation of beta-thalassemia in Thai patients, EUR J HAEMA, 66(2), 2001, pp. 126-129
Authors:
Perez-Ceballos, E
Vallejo, C
Cano, H
Ayala, F
Martinez, F
Moraleda, JM
Vicente, V
Citation: E. Perez-ceballos et al., Fatal upper and lower gastrointestinal cytomegalovirus disease following autologous peripheral blood stem cell transplantation, EUR J HAEMA, 66(2), 2001, pp. 130-132
Authors:
Anwar, R
Gallivan, L
Trinh, CH
Hill, FGH
Markham, AF
Citation: R. Anwar et al., Identification of a new Leu354Pro mutation responsible for factor XIII deficiency, EUR J HAEMA, 66(2), 2001, pp. 133-136
Authors:
Garderet, L
Bittencourt, H
Kaliski, A
Daniel, MT
Ribaud, P
Socie, G
Gluckman, E
Citation: L. Garderet et al., Treatment of T-prolymphocytic leukemia with nonmyeloablative allogeneic stem cell transplantation, EUR J HAEMA, 66(2), 2001, pp. 137-139
Authors:
Racchi, O
Rapezzi, D
Citation: O. Racchi et D. Rapezzi, Megathrombocytes and spurious thrombocytopenia, EUR J HAEMA, 66(2), 2001, pp. 140-141
Authors:
Hatzimichael, EC
Christou, L
Bai, M
Kolios, G
Kefala, L
Bourantas, KL
Citation: Ec. Hatzimichael et al., Serum levels of IL-6 and its soluble receptor (sIL-6R) in Waldenstrom's macroglobulinemia, EUR J HAEMA, 66(1), 2001, pp. 1-6
Authors:
Gillis, S
Amir, G
Bennett, M
Polliack, A
Citation: S. Gillis et al., Unexpectedly high incidence of hypoplastic/aplastic foci in bone marrow biopsies of hairy cell leukemia patients in remission following 2-chlorodeoxyadenosine therapy, EUR J HAEMA, 66(1), 2001, pp. 7-10